| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.23 | 0.2 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | 0.072 | 0.2 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.2 |
| mRNA | KIN001-270 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.2 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |